Pharmaceutics,
Journal Year:
2022,
Volume and Issue:
14(7), P. 1424 - 1424
Published: July 6, 2022
Most
living
organisms
in
both
the
plant
and
animal
kingdoms
have
evolved
processes
to
stay
tune
with
alternation
of
day
night,
optimize
their
physiology
as
a
function
light
supply.
In
mammals,
circadian
clock
relying
on
feedback
loops
between
key
transcription
factors
will
thus
control
temporally
regulated
pattern
expression
most
genes.
Modern
ways
life
highly
altered
synchronization
human
activities
clocks.
This
review
discusses
links
an
rise
pathologies.
We
then
sum
up
proofs
concept
advocating
for
integration
considerations
chronotherapy
health
care,
medicine,
pharmacotherapy.
Finally,
we
discuss
current
challenges
that
biology
must
face
tools
address
them.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(2), P. 400 - 400
Published: Jan. 31, 2023
A
novel
syndrome
called
long-haul
COVID
or
long
is
increasingly
recognized
in
a
significant
percentage
of
individuals
within
few
months
after
infection
with
SARS-CoV-2.
This
disorder
characterized
by
wide
range
persisting,
returning
even
new
but
related
symptoms
that
involve
different
tissues
and
organs,
including
respiratory,
cardiac,
vascular,
gastrointestinal,
musculo-skeletal,
neurological,
endocrine
systemic.
Some
overlapping
symptomatologies
exist
between
myalgic
encephalomyelitis/chronic
fatigue
(ME/CFS).
Very
much
like
ME/CFS,
infections
herpes
family
viruses,
immune
dysregulation,
the
persistence
inflammation
have
been
reported
as
most
common
pattern
for
development
COVID.
review
describes
several
factors
determinants
proposed,
elaborating
mainly
on
viral
persistence,
reactivation
latent
viruses
such
Epstein–Barr
virus
human
herpesvirus
6
which
are
also
associated
pathology
superantigen
activation
system,
disturbance
gut
microbiome,
multiple
tissue
damage
autoimmunity.
Based
these
factors,
we
propose
diagnostic
strategies
measurement
IgG
IgM
antibodies
against
SARS-CoV-2,
EBV,
HHV-6,
superantigens,
microbiota,
biomarkers
autoimmunity
to
better
understand
manage
this
multi-factorial
continues
affect
millions
people
world.
Frontiers in Nutrition,
Journal Year:
2022,
Volume and Issue:
9
Published: April 11, 2022
Nicotinamide
mononucleotide
(NNM)
is
an
orally
bioavailable
NAD+
precursor
that
has
demonstrated
beneficial
effects
against
aging
and
aging-associated
diseases
in
animal
models.
NMN
ultimately
converted
to
NAD+,
a
redox
cofactor
mediates
many
metabolic
enzymes.
also
serves
as
the
substrate
for
poly(ADP-ribose)
polymerase
(PARP)
sirtuins,
regulates
various
biological
processes,
such
metabolism,
DNA
repair,
gene
expression,
stress
responses.
Previous
mouse
models
showed
administration
can
increase
organs
ameliorate
aging-related
diseases,
obesity,
diabetes,
heart
failure,
stroke,
kidney
Alzheimer's
disease
through
NAD+-mediated
pathways.
However,
evidence
of
its
effect
on
humans
still
scarce.
In
this
study,
we
conducted
placebo-controlled,
randomized,
double
blind,
parallel-group
trial
investigate
safety
administered
efficacy
levels
thirty
healthy
subjects.
Healthy
volunteers
received
250
mg/day
(n
=
15)
or
placebo
12
weeks,
physiological
laboratory
tests
were
performed
during
period.
addition,
related
metabolites
whole
blood
examined.
Oral
supplementation
weeks
caused
no
abnormalities
tests,
obvious
adverse
observed.
significantly
increased
after
administration.
We
observed
significant
rise
nicotinic
acid
(NAMN)
levels,
but
not
NMN.
found
amount
was
strongly
correlated
with
pulse
rate
before
These
results
suggest
oral
safe
practical
strategy
boost
humans.
Clinical
Trial
Registration:
JRCT
[https://jrct.niph.go.jp/],
identifier:
[jRCTs041200034].
Biochemical Journal,
Journal Year:
2022,
Volume and Issue:
479(16), P. 1653 - 1708
Published: Aug. 31, 2022
Ischaemia-reperfusion
(I-R)
injury,
initiated
via
bursts
of
reactive
oxygen
species
produced
during
the
reoxygenation
phase
following
hypoxia,
is
well
known
in
a
variety
acute
circumstances.
We
argue
here
that
I-R
injury
also
underpins
elements
pathology
chronic,
inflammatory
diseases,
including
rheumatoid
arthritis,
ME/CFS
and,
our
chief
focus
and
most
proximally,
Long
COVID.
Ischaemia
may
be
fibrin
amyloid
microclot
blockage
capillaries,
for
instance
as
exercise
started;
reperfusion
necessary
corollary
when
it
finishes.
rehearse
mechanistic
evidence
these
occurrences
here,
terms
their
manifestation
oxidative
stress,
hyperinflammation,
mast
cell
activation,
production
marker
metabolites
related
activities.
Such
microclot-based
phenomena
can
explain
both
breathlessness/fatigue
post-exertional
malaise
observed
conditions,
many
other
observables.
The
recognition
processes
implies,
mechanistically,
therapeutic
benefit
potentially
to
had
from
antioxidants,
anti-inflammatories,
iron
chelators,
suitable,
safe
fibrinolytics,
and/or
anti-clotting
agents.
review
considerable
existing
consistent
with
this,
biochemical
mechanisms
involved.
Brain Behavior & Immunity - Health,
Journal Year:
2024,
Volume and Issue:
36, P. 100733 - 100733
Published: Feb. 2, 2024
A
subset
of
patients
experiences
persistent
fatigue
symptoms
after
COVID-19,
and
may
develop
long
COVID,
which
is
characterized
by
lasting
systemic
symptoms.
No
treatments
for
this
condition
have
been
validated
are
urgently
warranted.
In
pilot
study,
we
assessed
whether
treatment
with
low-dose
naltrexone
(LDN,
4.5
mg/day)
supplementation
NAD
+
through
iontophoresis
patches
could
improve
quality
life
in
36
moderate/severe
COVID-19.
We
detected
a
significant
increase
from
baseline
SF-36
survey
scores
12
weeks
(mean
total
score
36.5
[SD:
15.6]
vs.
52.1
[24.8];
p
<
0.0001),
suggestive
improvement
life.
Furthermore,
participants
scored
significantly
lower
on
the
Chalder
scale
(baseline:
25.9
[4.6],
weeks:
17.4
[9.7];
0.0001).
found
52
%
to
be
responders
treatment.
Treatment
was
generally
safe,
mild
adverse
events
previously
reported
LDN,
managed
dose
adjustments.
The
were
associated
mild,
short-lived
skin
irritation
25
patients.
Our
data
suggest
LDN
NAD+
safe
beneficial
Larger
randomized
controlled
trials
will
confirm
our
determine
patient
subpopulations
might
benefit
most
strategy.
Brain Communications,
Journal Year:
2024,
Volume and Issue:
6(2)
Published: Jan. 1, 2024
Abstract
Components
that
comprise
our
brain
parenchymal
and
cerebrovascular
structures
provide
a
homeostatic
environment
for
proper
neuronal
function
to
ensure
normal
cognition.
Cerebral
insults
(e.g.
ischaemia,
microbleeds
infection)
alter
cellular
physiologic
processes
within
the
neurovascular
unit
contribute
cognitive
dysfunction.
COVID-19
has
posed
significant
complications
during
acute
convalescent
stages
in
multiple
organ
systems,
including
brain.
Cognitive
impairment
is
prevalent
complication
patients,
irrespective
of
severity
SARS-CoV-2
infection.
Moreover,
overwhelming
evidence
from
vitro,
preclinical
clinical
studies
reported
SARS-CoV-2-induced
pathologies
components
are
associated
with
impairment.
Neurovascular
disruption
alters
coupling
response,
critical
mechanism
regulates
cerebromicrovascular
blood
flow
meet
energetic
demands
locally
active
neurons.
Normal
processing
achieved
through
response
involves
coordinated
action
cells
(i.e.
neurons
glia)
cell
types
endothelia,
smooth
muscle
pericytes).
However,
current
work
on
COVID-19-induced
yet
investigate
as
causal
factor.
Hence,
this
review,
we
aim
describe
SARS-CoV-2's
effects
how
they
can
impact
decline
disease.
Additionally,
explore
potential
therapeutic
interventions
mitigate
Given
great
both
individuals
public
health,
necessity
effort
fundamental
scientific
research
application
becomes
imperative.
This
integrated
endeavour
crucial
mitigating
deficits
induced
by
its
subsequent
burden
especially
vulnerable
population.
Cell & Bioscience,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: May 10, 2023
Abstract
Nicotinamide
adenine
dinucleotide
(NAD
+
)
is
a
critical
metabolite
that
acts
as
cofactor
in
energy
metabolism,
and
serves
cosubstrate
for
non-redox
NAD
-dependent
enzymes,
including
sirtuins,
CD38
poly(ADP-ribose)
polymerases.
metabolism
can
regulate
functionality
attributes
of
innate
adaptive
immune
cells
contribute
to
inflammatory
responses.
Thus,
the
manipulation
bioavailability
reshape
courses
immunological
diseases.
Here,
we
review
basics
biochemistry
its
roles
response,
discuss
current
challenges
future
translational
potential
research
development
therapeutics
diseases,
such
COVID-19.
Journal of Virology,
Journal Year:
2023,
Volume and Issue:
97(2)
Published: Jan. 23, 2023
Zika
virus
(ZIKV)
is
a
major
public
health
concern
of
international
proportions.
While
the
incidence
ZIKV
infections
has
declined
substantially
in
recent
years,
potential
for
reemergence
or
reintroduction
remains
high.
The Journal of Cardiovascular Aging,
Journal Year:
2022,
Volume and Issue:
2(4), P. 43 - 43
Published: Jan. 1, 2022
The
development
of
age-related
cardiovascular
(CV)
dysfunction
increases
the
risk
CV
disease
as
well
other
chronic
age-associated
disorders,
including
kidney
disease,
and
Alzheimer's
related
dementias.
Major
manifestations
that
increase
are
vascular
dysfunction,
primarily
endothelial
arterial
stiffening,
elevated
systolic
blood
pressure.
Declines
in
nitric
oxide
bioavailability
secondary
to
increased
oxidative
stress
inflammation
established
mechanisms
with
aging.
Moreover,
fundamental
aging,
termed
"hallmarks
aging"
extend
system
and,
such,
may
be
considered
aging".
These
represent
viable
therapeutic
targets
for
treating
Healthy
lifestyle
behaviors,
such
regular
aerobic
exercise
certain
dietary
patterns,
"first-line"
strategies
prevent
and/or
treat
dysfunction.
Despite
well-established
benefits
these
strategies,
many
older
adults
do
not
meet
recommended
guidelines
or
consume
a
healthy
diet.
Therefore,
it
is
important
establish
alternative
complementary
evidence-based
approaches
reverse
Targeting
aging
interventions
time-efficient
training,
food-derived
molecules,
nutraceuticals,
select
synthetic
pharmacological
agents
represents
promising
approach.
In
present
review,
we
will
highlight
emerging
topics
field
specific
focus
on
how
exercise,
nutrition/dietary
nutraceuticals
compounds
promote
part,
by
targeting
hallmarks
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(17), P. 10103 - 10103
Published: Sept. 3, 2022
Oxidative
stress
induced
by
neutrophils
and
hypoxia
in
COVID-19
pneumonia
leads
to
albumin
modification.
This
may
result
elevated
levels
of
advanced
oxidation
protein
products
(AOPPs)
lipoxidation
end-products
(ALEs)
that
trigger
oxidative
bursts
thus
participate
cytokine
storms,
accelerating
endothelial
lung
cell
injury,
leading
respiratory
distress.
In
this
study,
sixty-six
hospitalized
patients
with
symptoms
were
studied.
AOPPs-HSA
was
produced
vitro
treating
human
serum
(HSA)
chloramine
T.
The
interaction
malondialdehyde
HSA
studied
using
time-resolved
fluorescence
spectroscopy.
findings
revealed
a
significantly
level
AOPPs
on
admission
the
hospital
one
week
later
as
long
they
acute
phase
infection
when
compared
values
recorded
for
same
6-
12-months
post-infection.
Significant
negative
correlations
positive
with,
e.g.,
procalcitonin,
D-dimers,
lactate
dehydrogenase,
aspartate
transaminase,
radiological
scores
computed
tomography
(HRCT),
observed.
AOPPs/albumin
ratio
found
be
strongly
correlated
D-dimers.
We
suggest
oxidized
could
involved
pathophysiology.
Some
possible
clinical
consequences
modification
are
also
discussed.